Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T23515 |
VU-29
VU 29 |
GluR | Neuroscience |
VU-29 是代谢型谷氨酸 5(mGlu5)受体的正变构调节剂,对 rmGluR5 的 EC50为 9 nM,Ki 为 244 nM。相对于其他亚型,它对 mGluR5 具有选择性,对 rmGluR1/rmGluR2和 hmGluR4的 EC50分别为557 nM/1.5 μM 和 154 nM。 | |||
T10057 |
LTD4 antagonist 1
|
Others | Others |
LTD4 antagonist 1 is a potent and orally active antagonist of leukotriene D4 (LTD4; Ki: 0.57 nM). | |||
T38128 |
Leukotriene D4
Leukotriene D4 MaxSpec® Standard,LTD4 |
||
Leukotriene D4 (LTD4) is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A) produced by the metabolism of LTC4 by γ-glutamyl transpeptidase. It is the first cysteinyl-leukotriene metabolite of LTC4 . Like LTC4, LTD4-induced bronchoconstriction and enhanced vascular permeability contribute to the pathogenesis of asthma and acute hypersensitivity. LTD4 is equipotent to LTC4 in its biological activities, except that LTD4 is nearly 100-fold more effective in the contraction of... | |||
T36819 |
Ac-FLTD-CMK
|
Caspase | Apoptosis; Proteases/Proteasome |
Ac-FLTD-CMK 是由消皮素 D (GSDMDD) 衍生的抑制剂,具有对炎症性 caspases 特异性的抑制作用。Ac-FLTD-CMK 对 Ac-FLTD-CMK 对 caspases-1、caspases-4和 caspases-11有抑制作用 ,IC50分别为 为 46.7 nM、 1.49 μM 和 329 nM。 Ac-FLTD-CMK 对 caspases-1、caspases-4、 caspases-11均表现出有效性,但对凋亡相关的 caspase-3 无效。 | |||
TP1942L1 |
pep2-AVKI acetate(1315378-69-8 free base)
|
Others | Others |
pep2-AVKI acetate(1315378-69-8 free base) 选择性破坏 AMPA 受体亚基 GluA2(在 C 末端 PDZ 位点)与与 C 激酶 (PICK1) 相互作用的蛋白质结合的抑制剂肽。不影响 GluA2 与 GRIP 或 ABP 的结合,也不增加 AMPA 电流幅度或影响长期抑制 (LTD)。 | |||
TP1943 |
pep2-EVKI
|
||
pep2-EVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD). | |||
TP1942 |
pep2-AVKI
|
||
pep2-AVKI is an inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD). | |||
T16739 |
RG-12525
NID 525 |
Leukotriene Receptor; PPAR | DNA Damage/DNA Repair; GPCR/G Protein; Metabolism |
RG-12525(NID 525) 是一种可口服且具有选择性和竞争性的白三烯 D (LTD)拮抗剂,对 LTC4,LTD4 和 LTE4 诱导的豚鼠薄壁带收缩有抑制作用,IC50 值分别为 2.6 nM,2.5 nM 和 7 nM。RG-12525 对 CYP3A4 有抑制作用, Ki 值为 0.5 µM。RG-12525 是一种新型高效的 PPAR-γ 激动剂(IC50 值约为 60 nM),具有物种特异性,可用于研究哮喘。 | |||
TP1944 |
pep2-SVKI
|
||
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and |